Novolog (Pharm-Up 1966) Ltd reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was ILS 329.85 million compared to ILS 290.5 million a year ago. Net income was ILS 10.15 million compared to ILS 9.7 million a year ago. Basic earnings per share from continuing operations was ILS 0.02 compared to ILS 0.021 a year ago. Diluted earnings per share from continuing operations was ILS 0.02 compared to ILS 0.02 a year ago. For the nine months, sales was ILS 955.58 million compared to ILS 859.89 million a year ago. Net income was ILS 33.13 million compared to ILS 32.22 million a year ago. Basic earnings per share from continuing operations was ILS 0.066 compared to ILS 0.07 a year ago. Diluted earnings per share from continuing operations was ILS 0.064 compared to ILS 0.068 a year ago.